CanSino Biologics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
10 Aug 23 | Sell€3,402,662 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 1,014,800 | €3.35 | |
09 Aug 23 | Sell€36,278,805 | Capital Research and Management Company | Company | 10,437,269 | €3.48 | |
09 Aug 23 | Buy€19,326,189 | Goldman Sachs Group, Investment Banking and Securities Investments | Company | 5,822,269 | €3.32 | |
31 Jul 23 | Sell€1,673,773 | Capital Research and Management Company | Company | 476,600 | €3.51 | |
26 Jul 23 | Sell€3,704,179 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 1,118,275 | €3.31 | |
24 Jul 23 | Buy€2,385,396 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 781,600 | €3.05 | |
21 Jul 23 | Sell€2,909,521 | Capital Research and Management Company | Company | 1,000,000 | €2.91 | |
20 Jul 23 | Sell€1,867,180 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 654,915 | €2.85 | |
19 Jul 23 | Sell€2,862,089 | Capital Research and Management Company | Company | 1,000,000 | €2.86 | |
19 Jul 23 | Sell€684,045 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 238,400 | €2.87 | |
13 Jul 23 | Sell€1,255,300 | Capital Research and Management Company | Company | 400,000 | €3.14 | |
26 Jun 23 | Sell€3,211,880 | Capital Research and Management Company | Company | 1,024,600 | €3.13 | |
23 Jun 23 | Sell€1,212,956 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 421,200 | €2.88 | |
16 Jun 23 | Sell€2,795,659 | Capital Research and Management Company | Company | 808,200 | €3.46 | |
15 Jun 23 | Sell€4,483,834 | Capital Research and Management Company | Company | 1,343,800 | €3.34 | |
13 Jun 23 | Sell€1,387,945 | Capital Research and Management Company | Company | 421,000 | €3.30 | |
02 Jun 23 | Sell€980,640 | Capital Research and Management Company | Company | 272,800 | €3.59 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Employee Share Scheme | 277,650 | 0.112% |
Private Companies | 15,497,763 | 6.27% |
Institutions | 42,193,371 | 17.1% |
Individual Insiders | 68,877,512 | 27.9% |
General Public | 120,197,505 | 48.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,874,200 | €76.2m | 0% | no data | |||
17,874,200 | €76.2m | 0% | no data | |||
17,114,200 | €73.0m | 0% | no data | |||
15,195,441 | €64.8m | 0% | no data | |||
7,516,538 | €32.0m | 0% | no data | |||
6,377,458 | €27.2m | 0% | no data | |||
4,809,877 | €20.5m | 0% | 0.01% | |||
3,607,120 | €15.4m | 0% | no data | |||
3,474,600 | €14.8m | 0% | no data | |||
3,299,475 | €14.1m | 0% | no data | |||
2,883,810 | €12.3m | 0% | 1.38% | |||
2,778,861 | €11.8m | 0% | 0.01% | |||
2,610,895 | €11.1m | -3.11% | 0.02% | |||
2,019,139 | €8.6m | 0% | 0.02% | |||
1,732,962 | €7.4m | 0% | no data | |||
1,495,536 | €6.4m | 0% | 0.02% | |||
1,395,072 | €5.9m | 0% | 0.01% | |||
1,291,998 | €5.5m | 0% | 0.04% | |||
1,207,150 | €5.1m | 0% | no data | |||
1,000,859 | €4.3m | 0% | 0.05% | |||
1,000,056 | €4.3m | 0% | 1.83% | |||
982,194 | €4.2m | 0% | 0.01% | |||
959,720 | €4.1m | 0% | 0.02% | |||
900,919 | €3.8m | 0% | no data | |||
838,396 | €3.6m | 0% | 0.14% |